Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-11
1992-07-14
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514455, 549389, 549378, A61K 3135, C07D31192
Patent
active
051303329
ABSTRACT:
Novel oxolabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure utilizing compounds or compositions thereof are disclosed.
REFERENCES:
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4578399 (1986-03-01), Schorlemmer et al.
patent: 4639443 (1987-01-01), Kosley, Jr. et al.
patent: 4724238 (1988-02-01), Dohadwalla et al.
patent: 4740522 (1988-04-01), Hrib
patent: 4751224 (1988-06-01), Agarwal et al.
patent: 4963537 (1990-10-01), Kosley, Jr. et al.
Hoechst Roussel Pharmaceuticals Inc.
Ivy C. Warren
Owens Amelia A.
Wittekind Raymond R.
LandOfFree
Oxolabdanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxolabdanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxolabdanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-334945